Both schizophrenia and non-psychiatric groups have shown that lower HMW adiponectin levels are associated with higher body mass index, worse risk for coronary heart disease, higher number of metabolic syndrome criteria, greater insulin resistance, lower levels of HDL cholesterol, and higher levels of high sensitivity C-reactive protein (CRP) (33). This evidence concerns the gene ADIPOQ and schizophrenia.